Cannabinoids and Neuropsychiatric Disorders
Springer International Publishing
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Chapter title |
Cannabis and Depression
|
|---|---|
| Chapter number | 5 |
| Book title |
Cannabinoids and Neuropsychiatric Disorders
|
| Published in |
Advances in experimental medicine and biology, December 2020
|
| DOI | 10.1007/978-3-030-57369-0_5 |
| Pubmed ID | |
| Book ISBNs |
978-3-03-057368-3, 978-3-03-057369-0
|
| Authors |
Daniel Feingold, Aviv Weinstein, Feingold, Daniel, Weinstein, Aviv |
X Demographics
The data shown below were collected from the profiles of 133 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 24 | 18% |
| United States | 13 | 10% |
| Colombia | 5 | 4% |
| Peru | 3 | 2% |
| Venezuela, Bolivarian Republic of | 3 | 2% |
| Germany | 3 | 2% |
| Canada | 2 | 2% |
| Poland | 2 | 2% |
| Chile | 2 | 2% |
| Other | 11 | 8% |
| Unknown | 65 | 49% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 123 | 92% |
| Practitioners (doctors, other healthcare professionals) | 7 | 5% |
| Science communicators (journalists, bloggers, editors) | 2 | 2% |
| Scientists | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 151 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 151 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 19 | 13% |
| Researcher | 17 | 11% |
| Student > Master | 10 | 7% |
| Student > Ph. D. Student | 10 | 7% |
| Student > Doctoral Student | 8 | 5% |
| Other | 12 | 8% |
| Unknown | 75 | 50% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 28 | 19% |
| Neuroscience | 9 | 6% |
| Biochemistry, Genetics and Molecular Biology | 8 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 5% |
| Psychology | 5 | 3% |
| Other | 18 | 12% |
| Unknown | 76 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 267. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 April 2024.
All research outputs
#138,924
of 25,859,234 outputs
Outputs from Advances in experimental medicine and biology
#15
of 5,283 outputs
Outputs of similar age
#3,981
of 528,564 outputs
Outputs of similar age from Advances in experimental medicine and biology
#2
of 59 outputs
Altmetric has tracked 25,859,234 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,283 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 528,564 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 59 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.